0001181431-12-038276.txt : 20120628
0001181431-12-038276.hdr.sgml : 20120628
20120628141153
ACCESSION NUMBER: 0001181431-12-038276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120626
FILED AS OF DATE: 20120628
DATE AS OF CHANGE: 20120628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYCE RICHARD PAUL
CENTRAL INDEX KEY: 0001553037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52811
FILM NUMBER: 12932136
MAIL ADDRESS:
STREET 1: C/O PUMA BIOTECHNOLOGY, INC.
STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC.
CENTRAL INDEX KEY: 0001401667
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770683487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: (424) 248-6500
MAIL ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP
DATE OF NAME CHANGE: 20070601
4
1
rrd349676.xml
BRYCE F4
X0305
4
2012-06-26
0
0001401667
PUMA BIOTECHNOLOGY, INC.
PBYI
0001553037
BRYCE RICHARD PAUL
C/O PUMA BIOTECHNOLOGY, INC.
10880 WILSHIRE BOULEVARD, SUITE 2150
LOS ANGELES
CA
90024
0
1
0
0
SR VP, CLINICAL RESEARCH & DEV
STOCK OPTION (RIGHT TO BUY)
11.30
2012-06-26
4
A
0
105000
0
A
2022-06-26
COMMON STOCK
105000
105000
D
The vesting commencement date ("Vesting Commencement Date") of the option is June 20, 2012. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to Reporting Person's continued services with the Issuer.
/s/ Richard Paul Bryce
2012-06-28